Genomic Analysis
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,000
NCT06542432
Utility and Effectiveness of Polygenic Risk Scoring (PRS) for Coronary Artery Disease (CAD)
Phase: N/A
Role: Lead Sponsor
Start: Jan 1, 2025
Completion: Jul 1, 2029
Loading map...